MENU
+Compare
HTSUY
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$6.65
Change
-$0.15 (-2.21%)
Capitalization
1.87B

HTSUY Hisamitsu Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan... Show more

HTSUY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HTSUY with price predictions
Nov 28, 2025

Momentum Indicator for HTSUY turns positive, indicating new upward trend

HTSUY saw its Momentum Indicator move above the 0 level on November 26, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 14 similar instances where the indicator turned positive. In of the 14 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.092) is normal, around the industry mean (17.312). P/E Ratio (15.381) is within average values for comparable stocks, (72.847). HTSUY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). Dividend Yield (0.027) settles around the average of (0.030) among similar stocks. P/S Ratio (1.942) is also within normal values, averaging (55.504).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HTSUY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HTSUY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
HTSUY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

HTSUY paid dividends on June 10, 2024

Hisamitsu Pharmaceutical Co., Ltd. HTSUY Stock Dividends
А dividend of $0.07 per share was paid with a record date of June 10, 2024, and an ex-dividend date of February 28, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEKIX22.89N/A
N/A
DWS Emerging Markets Equity Inst
GSQTX36.82N/A
N/A
Goldman Sachs Small Cap Value Inv
CCCRX40.40N/A
N/A
Columbia Contrarian Core R
MNMCX15.20N/A
N/A
Manning & Napier Pro-Blend Mod Term L
RIVKX20.48N/A
N/A
American Funds International Vntg R-4

HTSUY and Stocks

Correlation & Price change

A.I.dvisor tells us that HTSUY and TKNO have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HTSUY and TKNO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
TKNO - HTSUY
4%
Poorly correlated
-5.36%
BFRI - HTSUY
4%
Poorly correlated
-0.11%
ORXOY - HTSUY
0%
Poorly correlated
N/A
HNSPF - HTSUY
0%
Poorly correlated
N/A
SWGHF - HTSUY
-1%
Poorly correlated
N/A
More

Groups containing HTSUY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HTSUY
1D Price
Change %
HTSUY100%
N/A
Pharmaceuticals: Generic
industry (213 stocks)
0%
Poorly correlated
+0.76%